Close the acquisition of Cosmos Capital Limited
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 4 Feb 2021
- Due
- 16 Mar 2021
- Delivered
- 9 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Closing Date (issuance of Offer Consideration)* March 16, 2021”
What we found
Evidence strength A What the grades mean
The company successfully completed the acquisition of Cosmos Capital Limited on March 9, 2021, which is prior to the March 16, 2021 deadline.
-
A Wize Pharma, Inc. 10-Q filed 2021-05-19
“On March 9, 2021, Cosmos Capital Limited was acquired by the Company.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Cosmos Capital Limited
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: 90% minimum acceptance condition; subject to the satisfaction or waiver of certain Conditions
- Depends on
- Shareholder, Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Wize Pharma, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-BGDE-023152 · Corrections policy